1. Home
  2. ASMB vs KNDI Comparison

ASMB vs KNDI Comparison

Compare ASMB & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • KNDI
  • Stock Information
  • Founded
  • ASMB 2005
  • KNDI 2002
  • Country
  • ASMB United States
  • KNDI China
  • Employees
  • ASMB N/A
  • KNDI N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • ASMB Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • ASMB Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • ASMB 139.8M
  • KNDI 96.3M
  • IPO Year
  • ASMB 2010
  • KNDI N/A
  • Fundamental
  • Price
  • ASMB $18.75
  • KNDI $1.20
  • Analyst Decision
  • ASMB Strong Buy
  • KNDI
  • Analyst Count
  • ASMB 3
  • KNDI 0
  • Target Price
  • ASMB $33.00
  • KNDI N/A
  • AVG Volume (30 Days)
  • ASMB 43.5K
  • KNDI 109.2K
  • Earning Date
  • ASMB 08-07-2025
  • KNDI 08-15-2025
  • Dividend Yield
  • ASMB N/A
  • KNDI N/A
  • EPS Growth
  • ASMB N/A
  • KNDI N/A
  • EPS
  • ASMB N/A
  • KNDI N/A
  • Revenue
  • ASMB $32,154,000.00
  • KNDI $127,569,613.00
  • Revenue This Year
  • ASMB $0.04
  • KNDI N/A
  • Revenue Next Year
  • ASMB N/A
  • KNDI N/A
  • P/E Ratio
  • ASMB N/A
  • KNDI N/A
  • Revenue Growth
  • ASMB 148.33
  • KNDI 3.21
  • 52 Week Low
  • ASMB $7.75
  • KNDI $0.89
  • 52 Week High
  • ASMB $19.93
  • KNDI $2.07
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 65.84
  • KNDI 52.54
  • Support Level
  • ASMB $18.01
  • KNDI $1.09
  • Resistance Level
  • ASMB $18.99
  • KNDI $1.17
  • Average True Range (ATR)
  • ASMB 0.84
  • KNDI 0.07
  • MACD
  • ASMB -0.05
  • KNDI 0.01
  • Stochastic Oscillator
  • ASMB 84.42
  • KNDI 61.23

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: